Key MicroRNA's and Their Targetome in Adrenocortical Cancer.

Abstract

Adrenocortical Carcinoma (ACC) is a rare but aggressive malignancy with poor prognosis and limited response to available systemic therapies. Although complete surgical resection gives the best chance for long-term survival, ACC has a two-year recurrence rate of 50%, which poses a therapeutic challenge. High throughput analyses focused on characterizing the molecular signature of ACC have revealed specific micro-RNAs (miRNAs) that are associated with aggressive tumor phenotypes. MiRNAs are small non-coding RNA molecules that regulate gene expression by inhibiting mRNA translation or degrading mRNA transcripts and have been generally implicated in carcinogenesis. This review summarizes the current insights into dysregulated miRNAs in ACC tumorigenesis, their known functions, and specific targetomes. In addition, we explore the possibility of particular miRNAs to be exploited as clinical biomarkers in ACC and as potential therapeutics.

• Authors: Marthe Chehade, Martyn Bullock, Anthony Glover, Gyorgy Hutvagner, Stan Sidhu
• Journal: Cancers (Cancers (Basel)) Vol. 12 Issue 8 (Aug 06 2020) ISSN: 2072-6694 [Print] Switzerland
• PMID: 32781574 (Publication Type: Journal Article, Review)